Advances in Primary Care: Cutting-Edge Pharmacology & Treatment Strategies
Primary care is a never-ending marathon.
Each day is packed… with urgent visits, scheduled appointments, prescription refills, chronic illness management, and challenging new diagnoses… your goal is to treat all your patients, provide them with the best care possible, and keep them healthy.
But the guidelines change continuously and keeping up with emerging evidence-based care can be time-consuming and overwhelming, leaving you unsure of how to treat all your patients…
We can help… join us for an incredible program taught by a faculty team of 21 experts, so that you can deliver the most comprehensive care to your patients.
You will get…
Latest evidence-based guidelines… including GOLD, GINA, AAFP, CDC, and more!
Medication updates for acute and chronic conditions
Lifestyle medicine integration for primary care
Practical solutions provided by interdisciplinary experts
Stay up to date in rapidly changing therapeutic areas while learning to manage commonly encountered conditions and improve patient outcomes. Walk away with practical and useful information and enhanced professional skills that you can implement immediately in clinical practice.
WHY THIS TRAINING STANDS OUT FROM OTHERS!
Developed to meet the real-world needs of primary care providers
Lead by primary care experts who are in the trenches every day
Evidence-based guidelines… from GINA, CDC, GOLD, ADA, ACLM, and more!
Information that you can immediately apply in your practice
The most current pharmacology content and opportunity to earn up to 14.0 pharmacology CE hours
See our amazing agenda and meet your primary care expert speakers!
Integrating Lifestyle Medicine in Primary Care Jessica Albores, MBA, FNP-C, DipACLM, CWS
Defining Lifestyle Medicine…
What is Lifestyle Medicine?
Discuss the 6 pillars of lifestyle medicine
How is Lifestyle Medicine Different from other related disciplines?
What is the evidence…
Interventions to prevent and treat chronic disease
Lifestyle-related chronic diseases… including obesity, hypertension, dyslipidemia, type 2 diabetes, heart failure, peripheral artery disease, breast cancer, dementia, and a few others
What are Lifestyle Medicine Interventions…
Prevention of developing lifestyle-related chronic illnesses
Strategies to integrate Lifestyle Medicine into daily practice
Strategies to implement lifestyle medicine quickly into short visits
Managing Chronic Liver Disease in Primary Care Amanda Chaney, DNP, FAANP, AF-AASLD
Abnormal LFTs
Reasons for Abnormal LFTs
Finding the “why”
When to Refer
Hepatitis C Update
Background
Diagnosis and Presentation
Treatment Options
Non-alcoholic Fatty Liver Disease
Background
Treatment Options
Consultations
Cirrhosis and its Complications
Cirrhosis Complications
Portal Hypertension — GI bleeding and Ascites
Infections
Pulmonary issues
Renal issues
Palliative Care
Transplant
Reflux & Heartburn with a Retroflex of Health & Wellness Melissa Dyrdal, MSN, APRN, FNP-BC
0.5 Pharmacology CE Hours
Reflux & Heartburn
Pathophysiology/effects
Typical vs. Atypical
Patient referrals
Comprehensive Evaluation
EGD/pH/HRM
US/HIDA
Gastric Emptying
Esophagram
Planimetry
CT
Treatment options
Lifestyle/diet
Medication
Endoscopic
Surgical
Medical Weight Management
Assessment/consult
Diagnostics/Labs
Processed Food Addiction
Treatment route
Quality of life/success
Education
Options
Referral(s)
Patient/provider relationship for lifelong disease
Openness/trust
Continued knowledge and education
Accountability
Follow through
Asthma Interventions: The GINA Guidelines Alicia Elam, PharmD
1.5 Pharmacology CE Hours
What is GINA?
Anti-Asthmatic Drugs and how they are employed in the GINA strategy
SABAs
LABAs + ICS
LAAC
ICS
LTR
GINA guidelines — the use of albuterol in the management of asthma
Previous asthma treatment guidelines vs. Current GINA strategy
US Boxed Warning associated with LABAs in the management of asthma
Alternative asthma treatments / other controller options
Managing COPD in Primary Care: Yes, You Can! Mike Hess, MPH, RPFT, RRT
0.5 Pharmacology CE Hours
COPD Pathogenesis & Epidemiology
Screening tools
Phenotypes/etiotypes
Diagnostic options
Treatment Options
Pharmacological management
Tobacco cessation strategies
Pulmonary rehabilitation
Oxygen therapy
Surgical and bronchoscopic interventions
Additional Resources
GOLD
ATS/ERS
Peer support groups
Can’t Miss Diagnoses in Primary Care Kristene Diggins, DNP, MBA, FAANP, CNE, NEA-BC, DC
Cardiovascular Assessment & Diagnosis — H & P, Specific pointers, Key exam findings in normal/abnormal exam, Differential Diagnosis: MI
Cerebrovascular Assessment & Diagnosis — H & P, specifics pointers, Key exam findings in normal/abnormal exam, Differential Diagnosis: CVA/ TIA
Pulmonary Assessment & Diagnosis — H & P specifics for the pulmonary exam, Key findings in normal exam/ abnormal, Differential Diagnosis of interest: PE
Timely Evidence-based Differential Diagnosis
Point of care Clinical Decision Support tools
Limitations of CDSS and other collaborative decision tools to effectively diagnose/timely
Evidence-based process of collaboration in primary care urgencies/ diagnosis
Primary Care Dermatology for the Non-Dermatology Provider Mikala Riddlesworth, PA-C, MMS
Acne
Dermatitis
Atopic
Allergic
Contact
Benign Lesions
Cysts/Lipoma
Nevi
Seborrheic/Solar Keratosis
Pre Malignant Lesions
Actinic Keratosis
Malignant Lesions
Basal Cell Carcinoma (BCC)
Squamous Cell Carcinoma (SCC)
Melanoma
Immunizations in Primary Care: Making a Difference Kathy Bay, DNP, RN, CENP, USN, ret
1.0 Pharmacology CE Hours
Current adult and child/adolescent recommendations for immunization
Child Immunization Schedule for 2023
Adult Immunization Schedule Changes for 2023
Covid-19
On the horizons
Vaccine safety tools utilized in the United States
VAERS
VSD
COVID-19 CISA Project
Importance of recommending immunizations to patients
Role of primary care providers
Patient Education/Dispelling myths
Record Keeping
Resources
Screening for Mental Health Issues in Primary Care Catherine Moore, MSN, PMHNP-BC
Importance of mental health assessment and treatment in primary care — Prevalence, Access to specialized treatment: often long waits or other barriers to engaging Mind-Body connection
Levels of integration — Coordinated vs. Integrated
Measurement-based care — Pros and cons, Considerations
Substance use — Diagnosing: symptom measure, clinical interview, Psychopharmacologic intervention, medical rule-outs
Safety Assessment and Planning — CSSR, Safety planning
Limitations or research and potential risks
Management of Food Allergies in Primary Care Erin Sinnaeve, DNP, FNP-C
Food Allergy Stats — global population and state rates of food allergy, most allergenic foods, anaphylaxis rates, hospitalizations, and medical procedure data, health disparities, quality of life impact
Diagnosing food allergy — the importance of history, IgE testing through skin and immunocap/RAST tests, IgE versus Non-IgE food allergy
Management of food allergy — education, treatment for anaphylaxis, school implications/forms, clinician role in the management of food allergy-related anxiety
Prevention — early Introduction, eczema treatment, breastfeeding
Endocrine Challenges in Primary Care Christina Dzioba, PhD, APRN, WHNP-BC, BC-ADM, FNP-BC, C-EFM
1.0 Pharmacology CE Hours
Metabolic Syndromes and Diabetes
Gut Health, genetics, and hormone dysregulation as key pathophysiology components
Prevention and Lifestyle Medicine
Treatments require a multifaceted approach and individualized plan
Watching and Waiting leads to missed opportunities and weight gain
Older adult considerations
Thyroid disorders
Gut health, Genetics, and hormone and immune system dysregulation lead to pathophysiologic changes
Hyperthyroid and Hypothyroid symptoms and management
Risk factors to consider in primary care
Older adult recommendations
Osteoporosis
Quality is just as important as quantity and is not just a problem in older adults
Key risk factors to consider
Primary care partnerships needed to help patients through treatment
BONUS SESSIONS!
Prescribing for Pain Management: Best Practices for Opioid and Non-Opioid Medications Debra Dermady-Ray, RN-BC, MS, ANP-BC
2.0 Pharmacology CE Hours
Pharmacokinetics to Guide Medication Decisions
Principles of Analgesia
Medications for Pain Management
Substance Use Disorder
Standard of Care for Scheduled Pain Medications
Respiratory Pharmacology: Pharmacokinetics, Indications for Use and Patient Monitoring Paul Langlois, APN, PhD, CCRN, CCNS
Tuberculosis (TB): Still Prevalent and Highly Contagious
Pulmonary Hypertension
Pneumonia
Botulinum Toxin Injections for Chronic Migraine Victoria Trott, PA-C, MMS, AQH
Migraine Headaches
Diagnosis
Aura — no Aura
International Classification of Headache Disorders (ICHD)
PREEMPT Protocol for Botulinum Toxins
Criteria
Documentation
Potential Adverse Effect
Insurance
Injection Process (Demonstration)
Materials Needed
Injection Sites (31 total)
Dosage
Frequency
Reconstitution
Documentation
Wake Up the Surgeon! Can’t Miss Abdominal Pain Diagnoses Patrick Heagey, MPAS, PA-C
Patient History — pertinent historical details related to a chief complaint of abdominal pain, risk factors, benign vs. urgent, visceral vs. parietal vs. referred
Physical Exam — findings leading to the diagnosis of an acute surgical abdomen, benign vs. urgent
Emergent and surgical management of several common potential life-threatening surgical abdominal emergencies
Differential dx
Acute appendicitis
GI Perforation
Ectopic pregnancy
Small bowel obstructions
Mesenteric Ischemia
Volvulus
Abdominal Aortic Aneurysm
Potential pitfalls in the management of acute abdominal pain in the geriatric population
Mythbusters: Genetics and Pharmacogenomics Nguyen Park, MS, PA-C, DFAAPA
The Current state of Genetics & Genomics Advances
MythsBusters Flow Chart
Genomic Competencies
Impact on Clinical Practice
Basics of genetics & genomics
Double Helix (Rosalind Franklin)
Double-Stranded vs. Single-Stranded DNA/RNA
DNA Points to Remember
Pharmacogenomics
The Human Genome: Your DNA
Genetic testing affects patient care
Newborn Screening
Mitochondrial
Direct-to-Consumer Genetic/Genomic Testing
Ethical, legal, and social issues surrounding genetics & genomics testing and therapies
Genetic Information Nondiscrimination Act (GINA)
Gene Therapy
Genetic Mutation/Replacement
Head, Shoulders, Knees and Toes: Office-Based Orthopaedic Evaluation Dennis Rivenburgh, MS, ATC, PA-C, DFAAPA
The orthopedic exam — overview, conditions, anatomy, focused history questions
Shoulder
Elbow
Hip
Knee
Ankle
Radiographic Imaging
Indications
Which views to order
Interpretation
Treatment Approaches
Physical therapy
Immobilization/Casting
Surgery
Introduction to Hormone Replacement Therapy James Paoletti, BS Pharmacy, FIACP, FAARFM
Goals of balanced physiologic hormones
Functions and benefits of estrogen, progesterone, and testosterone v
Patient Needs Assessment
Effects of supraphysiologic dosing of estrogen, progesterone, and testosterone
Estradiol
Progesterone
Dosage forms used for BHRT
Management of Type 2 Diabetes for Primary Care Matthew Kearney, MS, MPAS, PA-C
Complications — Macrovascular, Microvascular, and Neuropathy complications
Goals — Reduced HF Risk, Reduce risk of Neuropathy, Increased quality of Life
“Life is Dangerous, Wear a Helmet!” Concussion Assessment and Management Steven Cohen, MPA/HCA, PA-C
What is a Concussion?
“Not for Faint of Heart”
“Hold on to Your Helmets!”
Concussion Facts — A New Model-Symptom with Focused Therapies
Improving Recovery
What Should We Know?
Mild TBI — refer to GCS
Head Trauma — Blunt Trauma
Why Did I See My Provider (somatic complaints)
Studies and Physical Exam Findings
Additional Testing
SCAT 5 — Sports Concussion Assessment Toll 5
MACE
Mechanisms of Concussion
Adult Psych. Issues or Mental Health Disorders associated with concussion identified
Concerns to See a Provider
Research Into CTE
So, Where are we going with Concussion Research and Management?
When it’s More than just a Nightcap: Alcohol Use Disorder Deanna Bridge Najera, MPAS, MS, PA-C, DFAAPA
Impact of alcohol use disorder
Definitions related to alcohol consumption
Risks of heavy drinking
Benefits of screening for AUD and how to perform
Detox — outpatient and inpatient protocols
Medications for maintaining sobriety
Other supports for AUD
JNC8: Is it Still Great? Hypertension Treatment Guidelines Alicia Elam, PharmD
1.0 Pharmacology CE Hours
Joint National Committee Guidelines (JNC8) — Guideline Emphasis, Three Questions, Blood Pressure Goals
Why is JNC8 more lenient with BP control? HDFP, HSP, ANBP, VA Cooperative
Which Antihypertensive Classes are first line?
2nd, 3rd, and later line options for the treatment of HTN
What do Trials Matter? — ALLHAT and AASK
Exceptions to the JNC8 rule?
Follow-up with JNC8
Lifestyle changes
JNC8 vs. ACC/AHA 2017 and other guidelines
Frequently Asked Questions:
Innovative Business Model:
Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
The Legal Landscape: Yes and No:
The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
Quality Assurance: Unveiling the Real Deal:
Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
No coaching calls or scheduled sessions with the author.
No access to the author’s private Facebook group or web portal.
No entry to the author’s exclusive membership forum.
No direct email support from the author or their team.
We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.
Refund is acceptable:
Firstly, item is not as explained
Secondly, Item do not work the way it should.
Thirdly, and most importantly, support extension can not be used.
Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.
Reviews (0)
Reviews
There are no reviews yet.
Be the first to review “Advances in Primary Care: Cutting-Edge Pharmacology & Treatment Strategies” Cancel reply
Reviews
There are no reviews yet.